Our endpoint was to define the molecular mode of action of LRH‐1/NR5A2 agonistic activation in T1D cells, which is especially relevant considering that the diabetic milieu impedes the anti‐inflammatory characteristics of both human macrophages and DCs.25, 26, 27. Here, NR5A2 is linked to type 1 diabetes mellitus.